KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | - | ₹0.06 Cr | ₹0.06 Cr |
What is the latest Contingent Liabilities ratio of KERALA AYURVEDA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | ₹0.06 Cr |
| Mar2021 | ₹0.06 Cr |
How is Contingent Liabilities of KERALA AYURVEDA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | -100.00 | |
| Mar2022 | ₹0.06 Cr | 0.00 | |
| Mar2021 | ₹0.06 Cr | - | |
Compare Contingent Liabilities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹227.2 Cr | -13.2% | -17.3% | -54.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,349.0 Cr | -2.8% | -1% | 6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,543.0 Cr | -3.3% | 0.4% | -2.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,884.0 Cr | -3.1% | 2.9% | 36.9% | Stock Analytics | |
| CIPLA | ₹111,077.0 Cr | -2.7% | 5.3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,388.0 Cr | -4.1% | -3.7% | 3.7% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -13.2% |
-17.3% |
-54.7% |
| SENSEX | -2.2% |
-3.3% |
-8.8% |
You may also like the below Video Courses